Company Overview

Hannah Joseph Hospital Limited is an SME-listed multi-specialty tertiary care hospital founded in 2008 and based in Madurai, Tamil Nadu. Its Corporate Identification Number (CIN) is L74999TN2011PLC082860. The hospital operates with 133 beds and employs over 70 doctors. It has a focus on Neurosciences, Cardiac Sciences, Orthopaedics, and Traumatology.

Leadership

  • Dr. Moses Joseph Arunkumar: Promoter, Chairman & Managing Director. He has 25+ years in Neurosurgery, with a background from Apollo & CMC Vellore. He is a former President of the Tamil Nadu Association of Neurological Surgeons. His qualifications include M.B.B.S., M.Ch. (Neurosurgery), D.N.B. He was the recipient of the Dr. A.P.J. Abdul Kalam Inspiration Award in 2023.
  • Dr. Fenn Kavitha Fenn Arunkumar: Promoter & Whole-Time Director. She has 22+ years in Psychiatry & Healthcare, with a background from Apollo Speciality Hospital. Her qualifications include M.B.B.S., DPM, D.N.B. (Psychiatry). She leads policy execution and strategy implementation.

Mission and Vision

  • Mission: To improve the health of the community through a commitment to innovation and quality of patient care by employing staff committed to clinical excellence and compassionate care, utilizing cutting-edge technology and adopting the finest healthcare standards.
  • Vision: To be an international center of excellence in Neurosciences, Accident and Trauma care.

Strategic Initiative: Radiation Oncology Centre Expansion

  • The company has identified an opportunity to expand by building a Radiation Oncology Centre.
  • The objective is to build on its recognized Neurosciences expertise to offer comprehensive treatment for complex brain and spine tumors (surgery, radiation therapy, and chemotherapy) under one roof.
  • The initiative aims to strengthen the referral network across neighboring states, provide a multidisciplinary treatment approach, and improve clinical outcomes and patient convenience.
  • Expected benefits include additional IPD and OPD revenue streams, high-margin oncology and radiation services, enhanced patient retention, and cross-specialty utilization.
  • Adjacent land has already been acquired for this purpose-built cancer care infrastructure, providing future-ready capacity for long-term growth.

Technology Edge

  • BrainLab Navigation System: Provides real-time 3D image-guided surgical navigation for precise localization of brain and spinal tumors, enhancing accuracy in complex neurosurgical procedures and reducing surgical risk.
  • DTI Fiber Tracking 3.0 (AI): An AI-powered visualization tool for critical neural pathways that supports the preservation of functional brain regions, enabling safer tumor resections and surgical planning. The company states it was the first in South Asia/India to introduce this technology.

Financial Performance (Figures in ₹ Crores)

| Particulars | 31-Mar-26 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |

| Revenue from Operations | 92.05 | 77.53 | 63.41 | 54.62 |

| Revenue Growth Rate | 18.73% | 22.27% | 16.09% | - |

| EBITDA | 24.96 | 20.52 | 17.98 | 16.38 |

| EBITDA Margin | 27.12% | 26.47% | 28.35% | 29.99% |

| PAT | 11.18 | 7.21 | 4.07 | 1.01 |

| PAT Margin | 12.15% | 9.30% | 6.42% | 1.85% |

| Net Worth | 97.37 | 51.94 | 45.71 | 34.55 |

| Return on Equity (Avg Eq) | 15.00% | 14.77% | 10.13% | 3.14% |

| Basic / Diluted EPS (₹) | 6.32 | 4.32 | 2.47 | 0.63 |

| Total No. of Shares (Crore) | 2.27 | 1.67 | 1.67 | 1.63 |

| Price to Book Value (₹) | 42.89 | 31.10 | 27.38 | 21.13 |

Operational Highlights

  • Current Capacity: 133 beds.
  • Insurance Tie-ups: 34 companies.
  • The improvement in business performance is attributed to an enhanced service mix and improved revenue realization.

Strategic Milestones and Achievements

  • 2023: Launched 24/7 emergency medical services at Madurai Airport. Received AHPI Excellence Award (Single Specialty Hospital, >100 beds).
  • 2024: Introduced BrainLab Fibertracking Navigation (first in South Asia/India).
  • 2025: Achieved NABH (5th Edition) & NABL Accreditation. Launched DrNB Neurosurgery Program (6-year course). Won Time Business Award for Excellence in Neurosurgery & Trauma Care.
  • 2026: Ranked #2 Best Neurosurgery Hospital (All India).
  • Awards & Recognition (2025-2026):
  • India Today Eminent Doctors South '26.
  • Fortune India - Trusted Brands '25 (Dr. M.J. Arunkumar Featured).
  • Outlook Magazine '25 (Eminent Doctor — Top 10 Neurosurgery / Best Doctors South).
  • India Today & Search '25 (Ranked #2 Best Neurosurgery Hospital- All India).
  • Times Awards '25 (Excellence in Neurosurgery & Interventional Neuroradiology).
  • Won in the "Neurology: 100-Bedded Hospital Category" at TN Medclave 2025.

Investor Relations Partner

  • Kyro Relations, a division of Kyro Capital Private Limited, is the company's Investor Relations and Public Relations partner.
  • Contact: +91 7777839077, irpr@kyrocapital.in (Indore & Mumbai).
  • The disclaimer states that Kyro Relations and Kyro Capital maintain a strict Chinese Wall in accordance with UPSI guidelines. The division is headed by Mrs. Rachna Chelawat.